DiA Imaging Analysis
Acquired13 known investors
Find your way into DiA Imaging Analysis
Sign up to find every way you can get introduced to DiA Imaging Analysis
- Your email: who you already know at DiA Imaging Analysis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the DiA Imaging Analysis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
AI-based ultrasound analysis technology using machine learning to deliver fast and accurate clinical indications.
Also known as DiA · DiA Imaging Analysis Ltd.
Investors · 13
How we know: Mindset Venture's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: research · prweb.com · Not right? Tell us
How we know: research · prweb.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 6
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 5
launches, deals, and filingsPhilips agreed to acquire DiA for slightly less than $100 million, with most of the consideration paid upfront and the remainder tied to business milestones. The deal was disclosed to the Tel Aviv Stock Exchange on May 7, 2023 by largest shareholder Capital Point, which held a 15% stake and stood to receive about $7 million; DiA confirmed it on May 10, 2023, and CEO Hila Goldman-Aslan was to remain with the team.
$100M source ↗
Received its ninth U.S. FDA clearance, for a solution that assists with cardiac ultrasound image acquisition.
Closed a $14 million Series B led by a consortium of new and existing international investors, bringing total funding to $25 million, to expand its FDA-cleared and CE-marked product portfolio, pursue partnerships with ultrasound vendors, PACS and healthcare IT companies, resellers and distributors, and grow presence in Asia, Europe and the U.S.
$14M source ↗
Philips, which had previously partnered with DiA, acquired a minority interest in the company in 2020.
Closed a $5 million funding round led by Connecticut Innovations with participation from Defta Healthcare, existing investors and a government grant from the Israel Innovation Authority, to be used for market penetration with FDA/CE-approved tools and support teams in the U.S., Europe and Asia.
$5M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 11
primary sources listed
- GitHub - vdemichev/DiaNN: DIA-NN - a universal automated software suite for DIA proteomics data analysis. · GitHubgithub.com · web
- DiA Imaging Analysis — $24M Raised, Investors, Team & Alternativesstartuphub.ai · web
11 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does DiA Imaging Analysis do?
- AI-based ultrasound analysis technology using machine learning to deliver fast and accurate clinical indications.
- Who are DiA Imaging Analysis's investors?
- DiA Imaging Analysis's investors include Agate Medical Investments LP, Mindset Venture, Connecticut Innovations, DEFTA Partners, Israel Innovation Authority, Philips Ventures, XTX Markets.


